Gain Therapeutics names Joanne Taylor chief scientific officer, promotes Terenzio Ignoni to COO - GANX News | RalliesGain Therapeutics names Joanne Taylor chief scientific officer, promotes Terenzio Ignoni to COO
G
GANX• Executive appointments and departure
- Gain Therapeutics promoted Joanne Taylor to chief scientific officer, shifting her from senior vice president, research.
- Taylor joined in 2020; previously led neuroscience at Prescient Healthcare Group; held senior neuroscience research leadership roles at Eisai.
- Terenzio Ignoni was promoted to chief operating officer from senior vice president, technical operations and development.
- Ignoni joined in 2021; previously served as vice president, quality at Jazz Pharmaceuticals; held leadership roles at Gentium and Zambon Group.
- Clinical development executive Jonas Hannestad will depart in July 2026, following work on rexaceract’s early clinical program and IND filing.
GRFS
•
